Security key
03836J102
Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (APRE)
CUSIP: 03836J102
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 16,834,877
- Total 13F value
- $404,988,700
- Share change
- +356,311
- SEC-reported price per share
- $24.06
- Number of holders
- 65
- Value change
- +$5,638,022
- Number of buys
- 31
- Number of sells
- 24
- Shares outstanding
- 228,836,687
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
65
Top holders
10
APRE full security history
Ownership snapshot
Full 13F holder table
Aprea Therapeutics, Inc. SEC filings
Aprea Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of APRE - Aprea Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F
Highest disclosed value: $122,475,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC has the largest disclosed position value at $122.48M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Disclosed position value
Top 5
FMR LLC
$122.48M
Redmile Group, LLC
$87.98M
5AM Venture Management, LLC
$85.81M
Versant Venture Management, LLC
$71.91M
Consonance Capital Management LP
$48.56M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$122,475,000
3,158,207 shares
|
— | 30 Jun 2020 |
| Redmile Group, LLC |
13F
Company
|
—
denominator unverified
|
$87,981,000
2,268,718 shares
|
— | 30 Jun 2020 |
| 5AM Venture Management, LLC |
13F
Company
|
—
denominator unverified
|
$85,807,000
2,212,654 shares
|
— | 30 Jun 2020 |
| Versant Venture Management, LLC |
13F
Company
|
—
denominator unverified
|
$71,907,001
1,854,229 shares
|
— | 30 Jun 2020 |
| Consonance Capital Management LP |
13F
Company
|
—
denominator unverified
|
$48,560,000
1,252,185 shares
|
— | 30 Jun 2020 |
| Janus Henderson Group Ltd. |
13F
Company
|
—
denominator unverified
|
$36,631,000
944,594 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
65
Shares
16,834,877
Rows available
65
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
64
Q3 2020 holders
65
Holder diff
1
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|